论文部分内容阅读
目的观察美托洛尔联合螺内酯、卡托普利治疗慢性心力衰竭的疗效并探讨其临床应用价值。方法选择118例慢性心力衰竭患者,随机分为治疗组与对照组,治疗组在对照组应用螺内酯、卡托普利等常规治疗的基础上加用美托洛尔,连续治疗6个月,观察治疗前后心功能的改善情况。结果治疗组的总有效率为86.4%,对照组的总有效率为71.2%,差异有统计学的意义。结论美托洛尔联合螺内酯、卡托普利治疗慢性心力衰竭的疗效优于螺内酯、卡托普利等常规治疗。
Objective To observe the efficacy of metoprolol combined with spironolactone and captopril in the treatment of chronic heart failure and to explore its clinical value. Methods A total of 118 patients with chronic heart failure were randomly divided into treatment group and control group. Metoprolol was given to the treatment group on the basis of conventional treatment such as spironolactone and captopril, and the treatment group was continuously treated for 6 months. Before and after treatment to improve cardiac function. Results The total effective rate of the treatment group was 86.4%, the total effective rate of the control group was 71.2%, the difference was statistically significant. Conclusion Metoprolol combined with spironolactone and captopril is better than spironolactone and captopril in the treatment of chronic heart failure.